Search Results - "Trailokya, Abhijit"

  • Showing 1 - 16 results of 16
Refine Results
  1. 1

    Naftifine: A Topical Allylamine for Superficial Dermatophytosis by Trailokya, Abhijit A, Shirsat, Amar B, Madhu, R, Shah, Bela

    “…Dermatophytosis is a very common public health problem with high prevalence. Dermatophytes are a highly specialized set of filamentous fungi, which are adapted…”
    Get full text
    Journal Article
  2. 2
  3. 3
  4. 4
  5. 5

    Hypertension on Target with TENORMIN (HOTT) Study-Evaluation of the Effectiveness and Safety of Atenolol in Indian Population by Qayum Mukaddam, Manoj M Naik, Abhijit Trailokya

    Published in Heart India (01-01-2014)
    “…Background: Atenolol is a widely used anti-hypertensive drug worldwide. Despite well-studied from other population, due to the paucity of data from Indians,…”
    Get full text
    Journal Article
  6. 6

    Dabigatran - the First Approved DTI for SPAF by Trailokya, Abhijit, Hiremath, J S

    “…Atrial fibrillation (AF) is commonly occurring arrhythmia in clinical practice. AF is easy to recognize but difficult to treat. Stroke is the most devastating…”
    Get full text
    Journal Article
  7. 7

    Phase IV Studies: What Clinicians Need to Know by Trailokya, Abhijit, Srivastava, Ambrish, Mukaddam, Qayum, Chaudhry, Sunil, Patel, Kamlesh, Suryawanshi, Sachin, Naik, Manoj

    “…Phase IV trials, also known as postmarketing safety and efficacy studies and postmarketing surveillance (PMS) studies, occur after a drug or medical device has…”
    Get full text
    Journal Article
  8. 8

    Clinical Evidence of Evogliptin plus Metformin in Management of Type 2 Diabetes mellitus by Bajaj, Sarita, Aiwale, Amol, Trailokya, Abhijit, Sharma, Akhilesh

    “…Achieving adequate glycemic control in type 2 diabetes mellitus (T2DM) remains a difficult but achievable goal. Oral agents (OADs) are important option for…”
    Get full text
    Journal Article
  9. 9
  10. 10

    Fondaparinux in Acute Coronary Syndromes by Trailokya, Abhijit, Dhall, Anil, Kumbla, D K

    “…Anticoagulant therapy is a major component in the management of acute coronary syndromes (ACS). Anticoagulant-associated adverse events like heparin-induced…”
    Get full text
    Journal Article
  11. 11
  12. 12
  13. 13

    DemographIc Assessment and EValuation of DEgree of Lipid Control in High Risk Indian DySlipidemia PatiEnts (DIVERSE Study) by Malhotra, Naresh, Keshan, M K, Agarwal, Avinash, Kumar, R Anil, Trailokya, Abhijit, Dalvi, Kalpesh, Talele, Suhas

    “…Cardiovascular diseases (CVD's) are the major cause of morbidity and mortality in both developed and developing countries. Many clinical trials have…”
    Get full text
    Journal Article
  14. 14

    Acenocoumarol: A Review of Anticoagulant Efficacy and Safety by Trailokya, Abhijit, Hiremath, J S, Sawhney, Jps, Mishra, Y K, Kanhere, Vivek, Srinivasa, R, Tiwaskar, Mangesh

    “…Anticoagulant treatment is required for the treatment and prevention of thromboembolic disorders. Vitamin K antagonists are commonly used oral anticoagulants…”
    Get full text
    Journal Article
  15. 15

    Management Practices in Indian Patients with Uncontrolled Hypertension by Bharatia, Rajkumar, Chitale, Manoj, Saxena, Ganesh Narain, Kumar, Raman Ganesh, Chikkalingaiah, Trailokya, Abhijit, Dalvi, Kalpesh, Talele, Suhas

    “…Hypertension (HTN), being a major risk factor for cardiovascular diseases (CVDs), is an important issue of medical and public health. High blood pressure (BP)…”
    Get full text
    Journal Article
  16. 16